{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:34:22Z","timestamp":1771936462295,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T00:00:00Z","timestamp":1288224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00213-010-2030-5","type":"journal-article","created":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T03:58:19Z","timestamp":1288151899000},"page":"453-463","source":"Crossref","is-referenced-by-count":19,"title":["Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice"],"prefix":"10.1007","volume":"213","author":[{"given":"Emily","family":"Freeman-Daniels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl G.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn G.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,28]]},"reference":[{"key":"2030_CR1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2009.12.002","volume":"65","author":"A Adhikari","year":"2010","unstructured":"Adhikari A, Topiwala MA, Gordon JA (2010) Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 65:257\u2013269","journal-title":"Neuron"},{"key":"2030_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3565(25)11053-7","volume":"261","author":"AM Allan","year":"1992","unstructured":"Allan AM, Baier LD, Zhang X (1992) Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels. J Pharmacol Exp Ther 261:395\u2013402","journal-title":"J Pharmacol Exp Ther"},{"key":"2030_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(94)00473-0","volume":"264","author":"N Andrews","year":"1994","unstructured":"Andrews N, Hogg S, Gonzalez LE, File SE (1994) 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259\u2013264","journal-title":"Eur J Pharmacol"},{"key":"2030_CR4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0306-4530(99)00040-2","volume":"24","author":"E Appenrodt","year":"1999","unstructured":"Appenrodt E, Kroning G, Schwarzberg H (1999) Increased plasma ACTH in rats exposed to the elevated plus-maze is independent of the pineal gland. Psychoneuroendocrinology 24:833\u2013838","journal-title":"Psychoneuroendocrinology"},{"key":"2030_CR5","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1523\/JNEUROSCI.0563-04.2004","volume":"24","author":"SJ Bailey","year":"2004","unstructured":"Bailey SJ, Toth M (2004) Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors. J Neurosci 24:6343\u20136351","journal-title":"J Neurosci"},{"key":"2030_CR6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archpsyc.1986.01800120029007","volume":"43","author":"ML Barbaccia","year":"1986","unstructured":"Barbaccia ML, Costa E, Ferrero P, Guidotti A, Roy A, Sunderland T, Pickar D, Paul SM, Goodwin FK (1986) Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer\u2019s disease. Arch Gen Psychiatry 43:1143\u20131147","journal-title":"Arch Gen Psychiatry"},{"key":"2030_CR7","first-page":"259","volume":"2","author":"M Bourin","year":"2001","unstructured":"Bourin M, Hascoet M (2001) Drug mechanisms in anxiety. Curr Opin Investig Drugs 2:259\u2013265","journal-title":"Curr Opin Investig Drugs"},{"key":"2030_CR8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00174680","volume":"94","author":"KT Britton","year":"1988","unstructured":"Britton KT, Lee G, Koob GF (1988) Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test. Psychopharmacol (Berl) 94:306\u2013311","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/mol.63.1.53","volume":"63","author":"E Cagetti","year":"2003","unstructured":"Cagetti E, Liang J, Spigelman I, Olsen RW (2003) Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol Pharmacol 63:53\u201364","journal-title":"Mol Pharmacol"},{"key":"2030_CR10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0006-8993(88)90523-9","volume":"463","author":"AE Calogero","year":"1988","unstructured":"Calogero AE, Gallucci WT, Chrousos GP, Gold PW (1988) Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 463:28\u201336","journal-title":"Brain Res"},{"key":"2030_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(93)90956-I","volume":"234","author":"M Carli","year":"1993","unstructured":"Carli M, Tatarczynska E, Cervo L, Samanin R (1993) Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur J Pharmacol 234:215\u2013221","journal-title":"Eur J Pharmacol"},{"key":"2030_CR12","first-page":"901","volume-title":"Neuropsychopharmacology: the Fifth Generation of Progress. American College of Neuropsychopharmacology","author":"DS Charney","year":"2002","unstructured":"Charney DS, Drevets WC (2002) Neurobiological basis of anxiety disorders. In: Davis KL, Charney DS, Coyle J, Nemeroff C (eds) Neuropsychopharmacology: the Fifth Generation of Progress. American College of Neuropsychopharmacology. Lippincott Williams & Wilkins, Baltimore, MD, pp 901\u2013930"},{"key":"2030_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0896-6273(02)00753-5","volume":"35","author":"R Cossart","year":"2002","unstructured":"Cossart R, Epsztein J, Tyzio R, Becq H, Hirsch J, Ben-Ari Y, Crepel V (2002) Quantal release of glutamate generates pure kainate and mixed AMPA\/kainate EPSCs in hippocampal neurons. Neuron 35:147\u2013159","journal-title":"Neuron"},{"key":"2030_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0024-3205(91)90440-M","volume":"49","author":"E Costa","year":"1991","unstructured":"Costa E, Guidotti A (1991) Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 49:325\u2013344","journal-title":"Life Sci"},{"key":"2030_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-2236(96)20021-9","volume":"19","author":"JN Crawley","year":"1996","unstructured":"Crawley JN (1996) Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci 19:181\u2013182","journal-title":"Trends Neurosci"},{"key":"2030_CR16","doi-asserted-by":"crossref","DOI":"10.1002\/0470119055","volume-title":"What\u2019s wrong with my mouse: behavioral phenotyping of transgenic and knockout mice","author":"J Crawley","year":"2007","unstructured":"Crawley J (2007) What\u2019s wrong with my mouse: behavioral phenotyping of transgenic and knockout mice. John Wiley and Sons, Hoboken"},{"key":"2030_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.euroneuro.2007.07.007","volume":"18","author":"SL Dos","year":"2008","unstructured":"Dos SL, De Andrade TG, Zangrossi JH (2008) 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. Eur Neuropsychopharmacol 18:286\u2013294","journal-title":"Eur Neuropsychopharmacol"},{"key":"2030_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","volume":"65","author":"MS Fanselow","year":"2010","unstructured":"Fanselow MS, Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65:7\u201319","journal-title":"Neuron"},{"key":"2030_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","volume":"125","author":"SE File","year":"2001","unstructured":"File SE (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125:151\u2013157","journal-title":"Behav Brain Res"},{"key":"2030_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0091-3057(95)02108-6","volume":"54","author":"SE File","year":"1996","unstructured":"File SE, Gonzalez LE (1996) Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphe and ventral hippocampus. Pharmacol Biochem Behav 54:123\u2013128","journal-title":"Pharmacol Biochem Behav"},{"key":"2030_CR21","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1523\/JNEUROSCI.16-15-04810.1996","volume":"16","author":"SE File","year":"1996","unstructured":"File SE, Gonzalez LE, Andrews N (1996) Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16:4810\u20134815","journal-title":"J Neurosci"},{"key":"2030_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02245751","volume":"102","author":"SE File","year":"1990","unstructured":"File SE, Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of \u201cone-trial tolerance\u201d to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacol (Berl) 102:98\u2013101","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02245237","volume":"113","author":"SE File","year":"1994","unstructured":"File SE, Zangrossi H Jr, Sanders FL, Mabbutt PS (1994) Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacol (Berl) 113:543\u2013546","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I","volume":"6","author":"TF Freund","year":"1996","unstructured":"Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:347\u2013470","journal-title":"Hippocampus"},{"key":"2030_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-4328(01)00282-0","volume":"125","author":"R Gerlai","year":"2001","unstructured":"Gerlai R (2001) Gene targeting: technical confounds and potential solutions in behavioral brain research. Behav Brain Res 125:13\u201321","journal-title":"Behav Brain Res"},{"key":"2030_CR26","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1523\/JNEUROSCI.1211-05.2005","volume":"25","author":"JA Gordon","year":"2005","unstructured":"Gordon JA, Lacefield CO, Kentros CG, Hen R (2005) State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice. J Neurosci 25:6509\u20136519","journal-title":"J Neurosci"},{"key":"2030_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","volume":"54","author":"FG Graeff","year":"1996","unstructured":"Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129\u2013141","journal-title":"Pharmacol Biochem Behav"},{"key":"2030_CR28","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198522713.001.0001","volume-title":"The neuropsychology of anxiety: an enquiry into the function of the septo-hippocampal system","author":"JA Gray","year":"2003","unstructured":"Gray JA, McNaughton N (2003) The neuropsychology of anxiety: an enquiry into the function of the septo-hippocampal system. Oxford University Press, Oxford"},{"key":"2030_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-6357(93)90026-N","volume":"29","author":"G Griebel","year":"1993","unstructured":"Griebel G, Moreau JL, Jenck F, Martin JR, Misslin R (1993) Some critical determinants of the behavior of rats in the elevated plus-maze. Behav Process 29:37\u201347","journal-title":"Behav Process"},{"key":"2030_CR30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/416396a","volume":"416","author":"C Gross","year":"2002","unstructured":"Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396\u2013400","journal-title":"Nature"},{"key":"2030_CR31","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.95.25.15049","volume":"95","author":"LK Heisler","year":"1998","unstructured":"Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95:15049\u201315054","journal-title":"Proc Natl Acad Sci USA"},{"key":"2030_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","volume":"54","author":"S Hogg","year":"1996","unstructured":"Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"2030_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0028-3908(94)90064-7","volume":"33","author":"S Hogg","year":"1994","unstructured":"Hogg S, Andrews N, File SE (1994) Contrasting behavioural effects of 8-OH DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology 33:343\u2013348","journal-title":"Neuropharmacology"},{"key":"2030_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/edrv-12-2-118","volume":"12","author":"L Jacobson","year":"1991","unstructured":"Jacobson L, Sapolsky RM (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12:118\u2013134","journal-title":"Endocr Rev"},{"key":"2030_CR35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-3565(25)24515-3","volume":"272","author":"T Jolas","year":"1995","unstructured":"Jolas T, Schreiber R, Laporte AM, Chastanet M, De VJ, Glaser T, Adrien J, Hamon M (1995) Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272:920\u2013929","journal-title":"J Pharmacol Exp Ther"},{"key":"2030_CR36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0028-3908(91)90009-Z","volume":"30","author":"Y Kataoka","year":"1991","unstructured":"Kataoka Y, Shibata K, Miyazaki A, Inoue Y, Tominaga K, Koizumi S, Ueki S, Niwa M (1991) Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic. Neuropharmacology 30:475\u2013480","journal-title":"Neuropharmacology"},{"key":"2030_CR37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0014-2999(89)90803-0","volume":"168","author":"W Kostowski","year":"1989","unstructured":"Kostowski W, Plaznik A, Stefanski R (1989) Intra-hippocampal buspirone in animal models of anxiety. Eur J Pharmacol 168:393\u2013396","journal-title":"Eur J Pharmacol"},{"key":"2030_CR38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1523\/JNEUROSCI.07-07-01979.1987","volume":"7","author":"JC Lacaille","year":"1987","unstructured":"Lacaille JC, Mueller AL, Kunkel DD, Schwartzkroin PA (1987) Local circuit interactions between oriens\/alveus interneurons and CA1 pyramidal cells in hippocampal slices: electrophysiology and morphology. J Neurosci 7:1979\u20131993","journal-title":"J Neurosci"},{"key":"2030_CR39","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacol (Berl) 92:180\u2013185","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR40","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1523\/JNEUROSCI.5219-07.2008","volume":"28","author":"IL Lo","year":"2008","unstructured":"Lo IL, Gross C (2008) Alpha-Ca2+\/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. J Neurosci 28:6250\u20136257","journal-title":"J Neurosci"},{"key":"2030_CR41","first-page":"5","volume":"57 Suppl 6","author":"I Lucki","year":"1996","unstructured":"Lucki I (1996) Serotonin receptor specificity in anxiety disorders. J Clin Psychiatry 57 Suppl 6:5\u201310","journal-title":"J Clin Psychiatry"},{"key":"2030_CR42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","volume":"8","author":"JL Maguire","year":"2005","unstructured":"Maguire JL, Stell BM, Rafizadeh M, Mody I (2005) Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8:797\u2013804","journal-title":"Nat Neurosci"},{"key":"2030_CR43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","volume":"298","author":"AJ Mayorga","year":"2001","unstructured":"Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I (2001) Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298:1101\u20131107","journal-title":"J Pharmacol Exp Ther"},{"key":"2030_CR44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1152\/physrev.00041.2006","volume":"87","author":"BS McEwen","year":"2007","unstructured":"McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873\u2013904","journal-title":"Physiol Rev"},{"issue":"Suppl","key":"2030_CR45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/S0007125000296645","volume":"15","author":"BS McEwen","year":"1992","unstructured":"McEwen BS, Gould EA, Sakai RR (1992) The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry 15(Suppl):18\u201323","journal-title":"Br J Psychiatry"},{"key":"2030_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1997.tb48286.x","volume":"821","author":"BS McEwen","year":"1997","unstructured":"McEwen BS, Magarinos AM (1997) Stress effects on morphology and function of the hippocampus. Ann NY Acad Sci 821:271\u2013284","journal-title":"Ann NY Acad Sci"},{"key":"2030_CR47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008877-199808001-00220","volume":"9","author":"J Menard","year":"1998","unstructured":"Menard J, Treit D (1998) The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT. Behav Pharmacol 9:93\u2013101","journal-title":"Behav Pharmacol"},{"key":"2030_CR48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0149-7634(98)00056-6","volume":"23","author":"J Menard","year":"1999","unstructured":"Menard J, Treit D (1999) Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23:591\u2013613","journal-title":"Neurosci Biobehav Rev"},{"key":"2030_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","volume":"70","author":"MJ Millan","year":"2003","unstructured":"Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83\u2013244","journal-title":"Prog Neurobiol"},{"key":"2030_CR50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","volume":"24","author":"A Neumeister","year":"2004","unstructured":"Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC (2004) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24:589\u2013591","journal-title":"J Neurosci"},{"key":"2030_CR51","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1073\/pnas.95.18.10734","volume":"95","author":"CL Parks","year":"1998","unstructured":"Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998) Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 95:10734\u201310739","journal-title":"Proc Natl Acad Sci USA"},{"key":"2030_CR52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(02)01893-9","volume":"447","author":"T Pattij","year":"2002","unstructured":"Pattij T, Groenink L, Oosting RS, van der GJ M, RA OB (2002) GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129\/Sv background. Eur J Pharmacol 447:67\u201374","journal-title":"Eur J Pharmacol"},{"key":"2030_CR53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149\u2013167","journal-title":"J Neurosci Methods"},{"key":"2030_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s002130051128","volume":"147","author":"TJ Phillips","year":"1999","unstructured":"Phillips TJ, Hen R, Crabbe JC (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacol (Berl) 147:5\u20137","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR55","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.95.24.14476","volume":"95","author":"S Ramboz","year":"1998","unstructured":"Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95:14476\u201314481","journal-title":"Proc Natl Acad Sci USA"},{"key":"2030_CR56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","volume":"71","author":"LN Ravindran","year":"2010","unstructured":"Ravindran LN, Stein MB (2010) The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry 71:839\u2013854","journal-title":"J Clin Psychiatry"},{"key":"2030_CR57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-9384(99)00140-7","volume":"68","author":"RJ Rodgers","year":"1999","unstructured":"Rodgers RJ, Haller J, Holmes A, Halasz J, Walton TJ, Brain PF (1999) Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiol Behav 68:47\u201353","journal-title":"Physiol Behav"},{"key":"2030_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02253596","volume":"106","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacol (Berl) 106:102\u2013110","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02245704","volume":"113","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light\/dark tests of anxiety in mice. Psychopharmacol (Berl) 113:237\u2013242","journal-title":"Psychopharmacol (Berl)"},{"key":"2030_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0163-7258(00)00082-6","volume":"88","author":"JJ Sandford","year":"2000","unstructured":"Sandford JJ, Argyropoulos SV, Nutt DJ (2000) The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacol Ther 88:197\u2013212","journal-title":"Pharmacol Ther"},{"key":"2030_CR61","doi-asserted-by":"crossref","first-page":"14731","DOI":"10.1073\/pnas.97.26.14731","volume":"97","author":"Z Sarnyai","year":"2000","unstructured":"Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M (2000) Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci USA 97:14731\u201314736","journal-title":"Proc Natl Acad Sci USA"},{"key":"2030_CR62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(93)90531-L","volume":"249","author":"R Schreiber","year":"1993","unstructured":"Schreiber R, De Vry J (1993) Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Eur J Pharmacol 249:341\u2013351","journal-title":"Eur J Pharmacol"},{"key":"2030_CR63","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1523\/JNEUROSCI.20-08-02758.2000","volume":"20","author":"E Sibille","year":"2000","unstructured":"Sibille E, Pavlides C, Benke D, Toth M (2000) Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20:2758\u20132765","journal-title":"J Neurosci"},{"key":"2030_CR64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1523\/JNEUROSCI.20-03-01240.2000","volume":"20","author":"KH Skelton","year":"2000","unstructured":"Skelton KH, Nemeroff CB, Knight DL, Owens MJ (2000) Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 20:1240\u20131248","journal-title":"J Neurosci"},{"key":"2030_CR65","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1523\/JNEUROSCI.18-14-05275.1998","volume":"18","author":"SS Smith","year":"1998","unstructured":"Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, Hsu FC (1998) Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J Neurosci 18:5275\u20135284","journal-title":"J Neurosci"},{"key":"2030_CR66","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0028-3908(93)90062-8","volume":"32","author":"R Stefanski","year":"1993","unstructured":"Stefanski R, Palejko W, Bidzinski A, Kostowski W, Plaznik A (1993) Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacology 32:977\u2013985","journal-title":"Neuropharmacology"},{"key":"2030_CR67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","volume":"44","author":"D Treit","year":"1993","unstructured":"Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463\u2013469","journal-title":"Pharmacol Biochem Behav"},{"key":"2030_CR68","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.npp.1300531","volume":"29","author":"BJ Sickle Van","year":"2004","unstructured":"Van Sickle BJ, Xiang K, Tietz EI (2004) Transient plasticity of hippocampal CA1 neuron glutamate receptors contributes to benzodiazepine withdrawal-anxiety. Neuropsychopharmacology 29:1994\u20132006","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-2030-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-2030-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-2030-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:33:33Z","timestamp":1740645213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-2030-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,28]]},"references-count":68,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-2030-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,28]]}}}